Sean Mackay
CIK 1875501 · View on SEC EDGAR ↗
First SEC filing: Sept. 3, 2024 · Latest: Sept. 3, 2024
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 23, 2025 | LAB | S | 13,217 | $0.94 | $12,424 | 843,076 Direct | -1.54% | Disposed | -28.1% (price as of 2026-08-20) |
| May 22, 2025 | LAB | S | 12,536 | $1.00 | $12,536 | 856,293 Direct | -1.44% | Disposed | -32.4% (price as of 2026-08-20) |
| May 21, 2025 | LAB | S | 12,838 | $1.03 | $13,223 | 868,829 Direct | -1.46% | Disposed | -34.4% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 20, 2026 | LAB | Stock Option (Right to buy) | Common Stock (612,240) | $0.98 | March 20, 2036 | 612,240 | Acquired |
| March 21, 2025 | LAB | Stock Option (Right to Buy) | Common Stock (422,500) | $1.21 | March 21, 2035 | 422,500 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
LAB
Chief Business Officer(5)| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $471,888 | — | $340,817 | $396,158 | $469,680 | — | $14,000 | $1,692,543 |
| 2024 | $293,576 | — | — | — | $122,979 | — | — | $3,177,155 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.